Gulec Seza, Kuker Russ
Florida International University Herbert Wertheim College of Medicine, Departments of Surgery and Nuclear Medicine, Miami, USA, Phone: (786) 693 0821,Russ Kuker E-mail:
Mol Imaging Radionucl Ther. 2017 Feb 9;26(Suppl 1):16-23. doi: 10.4274/2017.26.suppl.03.
The rationale and objectives for radioactive iodine (RAI) ablation remain perplexing to many. This review addresses the meaning, clinical context and the goals of "ablation": the RAI treatment after a total thyroidectomy. This article also aims to clarify the definition of a total thyroidectomy and how a thyroid remnant can introduce a confounding factor in the postoperative management of patients with differentiated thyroid cancer. The implications of an existing thyroid remnant on RAI diagnostic imaging and serum thyroglobulin levels are discussed. This review provides a rational approach validating the utility of RAI remnant ablation regardless of the patient's risk stratification.
放射性碘(RAI)消融的基本原理和目标仍让许多人感到困惑。本综述探讨了“消融”的含义、临床背景及目标:全甲状腺切除术后的RAI治疗。本文还旨在阐明全甲状腺切除术的定义,以及甲状腺残留组织如何在分化型甲状腺癌患者的术后管理中引入一个混杂因素。讨论了现存甲状腺残留组织对RAI诊断成像和血清甲状腺球蛋白水平的影响。本综述提供了一种合理的方法,验证了无论患者风险分层如何,RAI残留组织消融的效用。